Search research articles
Contact Us
Filters
Showing results (21-30 of 616) with videos related to
Page
of 62
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
January 10, 2021
Reply to "Tacrolimus concentrations were not affected by glecaprevir/pibrentasvir treatment for hepatitis C virus infection in an adult living donor liver transplant recipient with uremia"
Ming-Lung Yu, Jia-Horng Kao
Clinical and Molecular Hepatology
|
March 20, 2020
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
Chung-Feng Huang, Ming-Lung Yu
The Journal of Infectious Diseases
|
September 13, 2023
Sharing Lessons Learned to Build Effective Hepatitis Elimination Programs
Ming-Lung Yu, John W Ward
Alimentary Pharmacology & Therapeutics
|
May 15, 2026
Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline-A Step Toward Functional Cure or a Marginal Margin?
Yao-Chun Hsu, Ming-Lung Yu
Clinical and Molecular Hepatology
|
February 19, 2024
Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer
Pin-Nan Cheng, Ming-Lung Yu
Clinical and Molecular Hepatology
|
March 5, 2024
Correspondence on Letter regarding "Toward hepatitis C virus elimination using artificial intelligence"
Ming-Ying Lu, Ming-Lung Yu
The Kaohsiung Journal of Medical Sciences
|
November 27, 2023
Hepatitis C virus micro-elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide
Chi-Ming Tai, Ming-Lung Yu
Clinical and Molecular Hepatology
|
February 12, 2019
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
Chung-Feng Huang, Ming-Lung Yu
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
July 26, 2018
Reply to "Rescue for interferon failures in HCV genotype 1/HBV dually infection"
Meng-Hsuan Hsieh, Ming-Lung Yu
Hepatitis Research and Treatment
|
January 22, 2011
Pegylated interferon and ribavirin treatment for hepatitis C virus infection
Tatehiro Kagawa, Emmet B Keeffe, Ming-Lung Yu
Page
of 62
Search research articles
Search
Showing results (21-30 of 616) with videos related to
Sort By:
Page
of 62
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
January 10, 2021
Reply to "Tacrolimus concentrations were not affected by glecaprevir/pibrentasvir treatment for hepatitis C virus infection in an adult living donor liver transplant recipient with uremia"
Ming-Lung Yu, Jia-Horng Kao
Clinical and Molecular Hepatology
|
March 20, 2020
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
Chung-Feng Huang, Ming-Lung Yu
The Journal of Infectious Diseases
|
September 13, 2023
Sharing Lessons Learned to Build Effective Hepatitis Elimination Programs
Ming-Lung Yu, John W Ward
Alimentary Pharmacology & Therapeutics
|
May 15, 2026
Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline-A Step Toward Functional Cure or a Marginal Margin?
Yao-Chun Hsu, Ming-Lung Yu
Clinical and Molecular Hepatology
|
February 19, 2024
Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer
Pin-Nan Cheng, Ming-Lung Yu
Clinical and Molecular Hepatology
|
March 5, 2024
Correspondence on Letter regarding "Toward hepatitis C virus elimination using artificial intelligence"
Ming-Ying Lu, Ming-Lung Yu
The Kaohsiung Journal of Medical Sciences
|
November 27, 2023
Hepatitis C virus micro-elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide
Chi-Ming Tai, Ming-Lung Yu
Clinical and Molecular Hepatology
|
February 12, 2019
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
Chung-Feng Huang, Ming-Lung Yu
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
July 26, 2018
Reply to "Rescue for interferon failures in HCV genotype 1/HBV dually infection"
Meng-Hsuan Hsieh, Ming-Lung Yu
Hepatitis Research and Treatment
|
January 22, 2011
Pegylated interferon and ribavirin treatment for hepatitis C virus infection
Tatehiro Kagawa, Emmet B Keeffe, Ming-Lung Yu
Page
of 62